搜索结果
疾病ID:TCMBANKDI023410
疾病名:Fragile X Syndrome
MeSH_Name:Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
HPO_Name:-
UMLS_Name:Disease or Syndrome
DO_Name:genetic disease
疾病类型:disease
DisGeNET_Link:C0016667
MeSH_Link:C16; C10
HPO_Link:-
UMLS_Link:T047
DO_Link:DOID:630
HERB_ID:-
疾病对应的植物
| ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
|---|
疾病对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN058519 | (-)-epigallocatechin-3-gallate; (-)-epigallocatechin 3-o-gallate;epigallocatechin gallate; galloyl-l-epigallocatechol; epigallocatechin 3-gallate; (-)-epigallocatechin gallate; | KBio2_000796; SpecPlus_000277; 50299_FLUKA; Spectrum3_000244; KBioGR_002002; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] ester; MLS000758300; DivK1c_006373; (−)-Epigallocatechin gallate; EGCG; SPBio_000035; (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; KBioSS_000796; Epigallocatechin gallate; Spectrum4_001541; (-)-epigallocatechin 3-gallate; Tea catechin; AIDS000674; KBio2_005932; 3,4,5-trihydroxybenzoic acid [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-chromanyl] ester; KBio1_001317; 989-51-5; AIDS-000674; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); KBio2_003364; Galloyl-L-epigallocatechol; SDCCGMLS-0066550.P001; (-)-Epigallocatechol gallate; ACon1_001054; Spectrum5_000102; Green tea extract; MEGxp0_001166; C09731; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; (-)-Epigallocatechin gallate; CCRIS 3729; Teavigo; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Spectrum2_000168; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxy-flavane-3-gallate; CHEBI:4806; (-)-epigallocatechin-3-gallate ; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; SPECTRUM210239; E4143_SIAL; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; Spectrum_000316; (-)-EGCG; KBio3_001128; BSPBio_001628; Epigallocatechol, 3-gallate, (-)-; Epigallocatechin-3-gallate; E4268_SIAL; epigallocatechin gallate ; epigallocatechin-3-gallate; (-)epigallocatechin-3-gallate ; EGCG; 989E515; [5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate; HMS2051K21; CS-1258; AC1L22IG; AK165605; Green tea polyphenols, Anagen; (-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard; AKOS015918182; CAS-989-51-5; Epigallocatechin gallate, primary pharmaceutical reference standard; W-5069; (-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate; (-)-Epigallocatechin gallate, analytical standard; Q-100914; DSSTox_RID_78830; AN-15867; DSSTox_GSID_29889; (-)-Epigallocatechol gallate; FT-0604392; NCGC00164319-04; Green tea extract; MEGxp0_001166; (-)-Epigallocatechin-3-o-gallate; Epigallocatechin 3-gallate; N1874; CHEBI:4806; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate; BG00814299; HMS3649E08; D0E9DB; Epigallocatechol, 3-gallate, (-)-; (-)-EpigallocatechinGallateHydrate; Epigallocatechin-3-gallate; AB0014381; BQM438CTEL; NC00078; ST51055716; Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material; SpecPlus_000277; Spectrum3_000244; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate; MLS000758300; (-)-Epigallocatechin gallate (EGCG); CCG-38378; Gallic acid, 3-ester with epigallocatechol, (-)-; SR-01000946601-1; NCGC00164319-01; (-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate; NCGC00164319-06; DSSTox_CID_567; MCULE-3341525983; Epigallocatechin monogallate, B; Tox21_303457; SAM001247031; 4awm; K791; 989-51-5; SR-01000946601; MFCD00075940; EGCG analogs; Galloyl-L-epigallocatechol; NCGC00164319-03; (-)-Epigallocatechin gallate, >=80% (HPLC), from green tea; Spectrum5_000102; CPD000449288; (-)-Epigallocatechin gallate; LMPK12030005; E0694; Teavigo; Epigallocatechin gallate analogs, Anagen; Epigallocatechin-3-monogallate; ACN-035233; Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; Sunphenon; Epigallocatechin gallate(EGCG); s2250; PF-EGCg 90; 3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate; 3,4,5-Trihydroxybenzoic acid (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester; MLS001424000; (-)-EGCG; ZINC3870412; KBio2_000796; EGCG cpd; KBioGR_002002; Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-; EGCG, Anagen; NCGC00257243-01; Tox21_201468; L-Epigallocatechin gallate; cid_65064; SPBio_000035; BG01747388; Epigallocatechin gallate; KBioSS_000796; Spectrum4_001541; (-)-epigallocatechin 3-gallate; DB12116; EPIGALOCATECHIN GALLATE; ANTIOXIDANT MODEL (TRAMP) -EPIGALLOCATECHIN GALLATE; KBio2_005932; I14-7747; D0U2BH; MCULE-7760530136; 2kdh; Epigallocatechin gallate, Anagen; AOB2839; SDCCGMLS-0066550.P001; 863-65-0; FR-109; ST097428; ACon1_001054; LS-2197; CCRIS 3729; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate; Epigallocate; GTPL7002; BDBM50070942; C22H18O11; GTPs,Anagen; SCHEMBL35258; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate; MolPort-001-741-358; DivK1c_006373; KB-206444; SR-01000759328; Teavigo;; EGCG; (-)-EPIGALLOCATECHIN GALLATE (GREEN TEA EXTRACT); HY-13653; (-)-Epigallocatechin gallate, >=95%; NCGC00259019-01; Tea catechin; DS-9030; SR-01000759328-6; SR-01000759328-5; KDH; AC1Q5X0Z; KBio1_001317; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate; (2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1[2H]-benzopyran-3,5,7-triol-3-(3,4,5-trihydroxybenzoate); NVP-XAA 723; KBio2_003364; EBD2138593; FT-0082796; NCGC00164319-02; C09731; (-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate; UNII-BQM438CTEL; DTXSID1029889; WMBWREPUVVBILR-WIYYLYMNSA-N; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate; (-)-Epigallocatehin gallate; Spectrum2_000168; (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate; (-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate); Catechin deriv.; SMR000449288; (-)-Epigallocatechin gallat; SPECTRUM210239; Epigallocic acid; Epigallocatcchin Gallate; KS-0000132O; BP-30205; CHEMBL297453; SC-47284; Spectrum_000316; 3oob; (-)-Epigallocatechin gallate, >=97.0% (HPLC); KBio3_001128; BSPBio_001628; epigallo-catechin gallate | C22H18O11 | 458.4g/mol | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O |
疾病对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE000785 | G6PD | G6PD1 | glucose-6-phosphate dehydrogenase |
| TCMBANKGE011318 | NCS1 | FLUP; FREQ | neuronal calcium sensor 1 |
| TCMBANKGE005232 | DLG3 | MRX; MRX90; NEDLG; PPP1R82; SAP102; XLMR | discs large MAGUK scaffold protein 3 |
| TCMBANKGE000235 | NTRK2 | EIEE58; GP145-TrkB; OBHD; TRKB; trk-B | neurotrophic receptor tyrosine kinase 2 |
| TCMBANKGE004481 | WASF1 | NEDALVS; SCAR1; WAVE; WAVE1 | WASP family member 1 |
| TCMBANKGE013320 | HDAC6 | CPBHM; HD6; JM21; PPP1R90 | histone deacetylase 6 |
| TCMBANKGE014455 | RAI1 | SMCR; SMS | retinoic acid induced 1 |
| TCMBANKGE000915 | BMPR2 | BMPR-II; BMPR3; BMR2; BRK-3; POVD1; PPH1; T-ALK | bone morphogenetic protein receptor type 2 |
| TCMBANKGE014158 | VIP | PHM27 | vasoactive intestinal peptide |
| TCMBANKGE009092 | F9 | F9 p22; FIX; HEMB; P19; PTC; THPH8 | coagulation factor IX |
| TCMBANKGE006517 | SLC1A2 | EAAT2; EIEE41; GLT-1; HBGT | solute carrier family 1 member 2 |
| TCMBANKGE004990 | RCAN1 | ADAPT78; CSP1; DSC1; DSCR1; MCIP1; RCN1 | regulator of calcineurin 1 |
| TCMBANKGE003689 | MFAP1 | AMP | microfibril associated protein 1 |
| TCMBANKGE008011 | HTR2A | 5-HT2A; HTR2 | 5-hydroxytryptamine receptor 2A |
| TCMBANKGE004703 | GABRD | EIG10; EJM7; GEFSP5 | gamma-aminobutyric acid type A receptor subunit delta |
| TCMBANKGE010781 | BRCA2 | BRCC2; BROVCA2; FACD; FAD; FAD1; FANCD; FANCD1; GLM3; PNCA2; XRCC11 | BRCA2 DNA repair associated |
| TCMBANKGE000392 | PGD | 6PGD | phosphogluconate dehydrogenase |
| TCMBANKGE001015 | RAC1 | MIG5; MRD48; Rac-1; TC-25; p21-Rac1 | Rac family small GTPase 1 |
| TCMBANKGE008151 | SPARC | BM-40; OI17; ON; ONT | secreted protein acidic and cysteine rich |
| TCMBANKGE001103 | MDM2 | ACTFS; HDMX; LSKB; hdm2 | MDM2 proto-oncogene |
| TCMBANKGE008622 | WNT7A | Wnt-7a | Wnt family member 7A |
| TCMBANKGE006259 | NBEA | BCL8B; LYST2 | neurobeachin |
| TCMBANKGE007365 | IGFALS | ACLSD; ALS | insulin like growth factor binding protein acid labile subunit |
| TCMBANKGE002833 | MED12 | ARC240; CAGH45; FGS1; HOPA; Kto; MED12S; OHDOX; OKS; OPA1; TNRC11; TRAP230 | mediator complex subunit 12 |
| TCMBANKGE013087 | ALPI | IAP | alkaline phosphatase, intestinal |
| TCMBANKGE012856 | ATXN3 | AT3; ATX3; JOS; MJD; MJD1; SCA3 | ataxin 3 |
| TCMBANKGE008480 | ICAM5 | TLCN; TLN | intercellular adhesion molecule 5 |
| TCMBANKGE001536 | DLD | DLDD; DLDH; E3; GCSL; LAD; OGDC-E3; PHE3 | dihydrolipoamide dehydrogenase |
| TCMBANKGE003699 | GSN | ADF; AGEL | gelsolin |
| TCMBANKGE001136 | MECP2 | AUTSX3; MRX16; MRX79; MRXS13; MRXSL; PPMX; RS; RTS; RTT | methyl-CpG binding protein 2 |
| TCMBANKGE009435 | PPP1R12A | GUBS; M130; MBS; MYPT1 | protein phosphatase 1 regulatory subunit 12A |
| TCMBANKGE013872 | HSPG2 | HSPG; PLC; PRCAN; SJA; SJS; SJS1 | heparan sulfate proteoglycan 2 |
| TCMBANKGE000047 | AKT1 | AKT; CWS6; PKB; PKB-ALPHA; PRKBA; RAC; RAC-ALPHA | AKT serine/threonine kinase 1 |
| TCMBANKGE003371 | ADCYAP1 | PACAP | adenylate cyclase activating polypeptide 1 |
| TCMBANKGE012107 | CFP | BFD; PFC; PFD; PROPERDIN | complement factor properdin |
| TCMBANKGE009369 | PPP2R5E | B56E; B56epsilon | protein phosphatase 2 regulatory subunit B'epsilon |
| TCMBANKGE000060 | CRHR1 | CRF-R; CRF-R-1; CRF-R1; CRF1; CRFR-1; CRFR1; CRH-R-1; CRH-R1; CRHR; CRHR1L | corticotropin releasing hormone receptor 1 |
| TCMBANKGE007428 | ADCY1 | AC1; DFNB44 | adenylate cyclase 1 |
| TCMBANKGE010656 | PTPN5 | PTPSTEP; STEP; STEP61 | protein tyrosine phosphatase non-receptor type 5 |
| TCMBANKGE008969 | IAPP | DAP; IAP | islet amyloid polypeptide |
| TCMBANKGE004021 | FMR1 | FMRP; FRAXA; POF; POF1 | FMRP translational regulator 1 |
| TCMBANKGE000298 | SOD1 | ALS; ALS1; HEL-S-44; IPOA; SOD; STAHP; hSod1; homodimer | superoxide dismutase 1 |
| TCMBANKGE000305 | PIK3CD | APDS; IMD14; P110DELTA; PI3K; p110D | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
| TCMBANKGE005437 | TDRD3 | - | tudor domain containing 3 |
| TCMBANKGE009334 | SDC2 | CD362; HSPG; HSPG1; SYND2 | syndecan 2 |
| TCMBANKGE004842 | SRRM2 | 300-KD; CWF21; Cwc21; HSPC075; SRL300; SRm300 | serine/arginine repetitive matrix 2 |
| TCMBANKGE013322 | FXR1 | FXR1P; MYOPMIL; MYORIBF | FMR1 autosomal homolog 1 |
| TCMBANKGE000606 | NRG1 | ARIA; GGF; GGF2; HGL; HRG; HRG1; HRGA; MST131; MSTP131; NDF; NRG1-IT2; SMDF | neuregulin 1 |
| TCMBANKGE010273 | REST | DFNA27; GINGF5; HGF5; NRSF; WT6; XBR | RE1 silencing transcription factor |
| TCMBANKGE008729 | PKP4 | p0071 | plakophilin 4 |
| TCMBANKGE010269 | RANGAP1 | Fug1; RANGAP; SD | Ran GTPase activating protein 1 |
| TCMBANKGE006909 | GRM1 | GPRC1A; MGLU1; MGLUR1; PPP1R85; SCA44; SCAR13 | glutamate metabotropic receptor 1 |
| TCMBANKGE002677 | SLC6A8 | CCDS1; CRT; CRTR; CT1; CTR5 | solute carrier family 6 member 8 |
| TCMBANKGE000275 | STXBP1 | MUNC18-1; N-Sec1; NSEC1; P67; RBSEC1; UNC18; unc-18A; unc18-1 | syntaxin binding protein 1 |
| TCMBANKGE000243 | LMNA | CDCD1; CDDC; CMD1A; CMT2B1; EMD2; FPL; FPLD; FPLD2; HGPS; IDC; LDP1; LFP; LGMD1B; LMN1; LMNC; LMNL1; MADA; PRO1 | lamin A/C |
| TCMBANKGE005172 | NUFIP2 | 182-FIP; 82-FIP; FIP-82; PIG1 | nuclear FMR1 interacting protein 2 |
| TCMBANKGE000521 | PLCG1 | NCKAP3; PLC-II; PLC1; PLC148; PLCgamma1 | phospholipase C gamma 1 |
| TCMBANKGE005732 | SYN1 | MRX50; SYN1a; SYN1b; SYNI | synapsin I |
| TCMBANKGE000078 | BRD4 | CAP; HUNK1; HUNKI; MCAP | bromodomain containing 4 |
| TCMBANKGE011061 | GRIK1 | EAA3; EEA3; GLR5; GLUR5; GluK1; gluR-5 | glutamate ionotropic receptor kainate type subunit 1 |
| TCMBANKGE013713 | SHBG | ABP; SBP; TEBG | sex hormone binding globulin |
| TCMBANKGE005082 | APOA1 | HPALP2; apo(a) | apolipoprotein A1 |
| TCMBANKGE013679 | DICER1 | DCR1; Dicer; Dicer1e; GLOW; HERNA; K12H4.8-LIKE; MNG1; RMSE2 | dicer 1, ribonuclease III |
| TCMBANKGE001126 | NFE2L2 | HEBP1; IMDDHH; NRF2; Nrf-2 | nuclear factor, erythroid 2 like 2 |
| TCMBANKGE011410 | NRF1 | ALPHA-PAL | nuclear respiratory factor 1 |
| TCMBANKGE008899 | IDS | ID2S; MPS2; SIDS | iduronate 2-sulfatase |
| TCMBANKGE011388 | FXR2 | FMR1L2; FXR2P | FMR1 autosomal homolog 2 |
| TCMBANKGE009368 | USF1 | FCHL; FCHL1; HYPLIP1; MLTF; MLTFI; UEF; bHLHb11 | upstream transcription factor 1 |
| TCMBANKGE001182 | SIRT1 | SIR2; SIR2L1; SIR2alpha | sirtuin 1 |
| TCMBANKGE004724 | FBN1 | ACMICD; ECTOL1; FBN; GPHYSD2; MASS; MFLS; MFS1; OCTD; SGS; SSKS; WMS; WMS2 | fibrillin 1 |
| TCMBANKGE000119 | PDE4D | ACRDYS2; DPDE3; HSPDE4D; PDE43; PDE4DN2; STRK1 | phosphodiesterase 4D |
| TCMBANKGE001524 | SKI | SGS; SKV | SKI proto-oncogene |
| TCMBANKGE011914 | INPP5K | MDCCAID; PPS; SKIP | inositol polyphosphate-5-phosphatase K |
| TCMBANKGE004398 | CTCF | CFAP108; FAP108; MRD21 | CCCTC-binding factor |
| TCMBANKGE000221 | GRIA2 | GLUR2; GLURB; GluA2; GluR-K2; HBGR2; gluR-2; gluR-B | glutamate ionotropic receptor AMPA type subunit 2 |
| TCMBANKGE000307 | PIK3CB | P110BETA; PI3K; PI3KBETA; PIK3C1 | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
| TCMBANKGE010402 | NF1 | NFNS; VRNF; WSS | neurofibromin 1 |
| TCMBANKGE008172 | MAOA | BRNRS; MAO-A | monoamine oxidase A |
| TCMBANKGE009848 | ARSD | ASD | arylsulfatase D |
| TCMBANKGE002073 | MEF2A | ADCAD1; RSRFC4; RSRFC9; mef2 | myocyte enhancer factor 2A |
| TCMBANKGE001176 | CAT | - | catalase |
| TCMBANKGE005810 | HTT | HD; IT15; LOMARS | huntingtin |
| TCMBANKGE000823 | GABPA | E4TF1-60; E4TF1A; NFT2; NRF2; NRF2A; RCH04A07 | GA binding protein transcription factor subunit alpha |
| TCMBANKGE000356 | SLC12A2 | BSC; BSC2; NKCC1; PPP1R141 | solute carrier family 12 member 2 |
| TCMBANKGE003418 | GRM5 | GPRC1E; MGLUR5; PPP1R86; mGlu5 | glutamate metabotropic receptor 5 |
| TCMBANKGE008334 | MBD5 | MRD1 | methyl-CpG binding domain protein 5 |
| TCMBANKGE000956 | NR1H4 | BAR; FXR; HRR-1; HRR1; PFIC5; RIP14 | nuclear receptor subfamily 1 group H member 4 |
| TCMBANKGE011200 | ADAM10 | AD10; AD18; CD156c; CDw156; HsT18717; MADM; RAK; kuz | ADAM metallopeptidase domain 10 |
| TCMBANKGE005339 | BCR | ALL; BCR1; CML; D22S11; D22S662; PHL | BCR activator of RhoGEF and GTPase |
| TCMBANKGE000126 | NFE2L1 | LCR-F1; NRF1; TCF11 | nuclear factor, erythroid 2 like 1 |
| TCMBANKGE000835 | APP | AAA; ABETA; ABPP; AD1; APPI; CTFgamma; CVAP; PN-II; PN2; preA4 | amyloid beta precursor protein |
| TCMBANKGE000109 | ACTB | BRWS1; PS1TP5BP1 | actin beta |
| TCMBANKGE003046 | AVP | ADH; ARVP; AVP-NPII; AVRP; VP | arginine vasopressin |
| TCMBANKGE001109 | ALPP | ALP; ALPI; IAP; PALP; PLAP; PLAP-1 | alkaline phosphatase, placental |
| TCMBANKGE008240 | MSH2 | COCA1; FCC1; HNPCC; HNPCC1; LCFS2; hMSH2 | mutS homolog 2 |
| TCMBANKGE000445 | CD44 | CDW44; CSPG8; ECMR-III; HCELL; HUTCH-I; IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1 | CD44 molecule (Indian blood group) |
| TCMBANKGE002584 | CHD7 | CRG; HH5; IS3; KAL5 | chromodomain helicase DNA binding protein 7 |
| TCMBANKGE010825 | NUP98 | ADIR2; NUP196; NUP96; Nup98-96 | nucleoporin 98 and 96 precursor |
| TCMBANKGE005630 | DSTN | ACTDP; ADF; HEL32; bA462D18.2 | destrin, actin depolymerizing factor |
| TCMBANKGE010271 | NHS | CTRCT40; CXN; SCML1 | NHS actin remodeling regulator |
| TCMBANKGE013267 | ARHGEF9 | COLLYBISTIN; EIEE8; HPEM-2; PEM-2; PEM2 | Cdc42 guanine nucleotide exchange factor 9 |
| TCMBANKGE014504 | ST14 | ARCI11; HAI; MT-SP1; MTSP1; PRSS14; SNC19; TADG15; TMPRSS14 | ST14 transmembrane serine protease matriptase |
| TCMBANKGE001647 | PVALB | D22S749 | parvalbumin |
| TCMBANKGE013192 | KIAA1109 | ALKKUCS; FSA; Tweek | KIAA1109 |
| TCMBANKGE011904 | PDE2A | CGS-PDE; PDE2A1; PED2A4; cGSPDE | phosphodiesterase 2A |
| TCMBANKGE014557 | ANXA1 | ANX1; LPC1 | annexin A1 |
| TCMBANKGE000642 | PAK1 | IDDMSSD; PAKalpha; alpha-PAK; p65-PAK | p21 (RAC1) activated kinase 1 |
| TCMBANKGE007230 | FXN | CyaY; FA; FARR; FRDA; X25 | frataxin |
| TCMBANKGE006003 | APRT | AMP; APRTD | adenine phosphoribosyltransferase |
| TCMBANKGE006453 | LGALS4 | GAL4; L36LBP | galectin 4 |
| TCMBANKGE004986 | ANG | ALS9; HEL168; RAA1; RNASE4; RNASE5 | angiogenin |
| TCMBANKGE001044 | RPS6KB1 | PS6K; S6K; S6K-beta-1; S6K1; STK14A; p70 S6KA; p70(S6K)-alpha; p70-S6K; p70-alpha | ribosomal protein S6 kinase B1 |
| TCMBANKGE011468 | DLG4 | MRD62; PSD95; SAP-90; SAP90 | discs large MAGUK scaffold protein 4 |
| TCMBANKGE000286 | GSK3B | - | glycogen synthase kinase 3 beta |
| TCMBANKGE001125 | IGF1 | IGF; IGF-I; IGFI; MGF | insulin like growth factor 1 |
| TCMBANKGE000419 | SMS | MRSR; SPMSY; SRS; SpS | spermine synthase |
| TCMBANKGE014325 | SCN2A | BFIC3; BFIS3; BFNIS; EIEE11; HBA; HBSCI; HBSCII; NAC2; Na(v)1.2; Nav1.2; SCN2A1; SCN2A2 | sodium voltage-gated channel alpha subunit 2 |
| TCMBANKGE014543 | KCNQ2 | BFNC; EBN; EBN1; ENB1; HNSPC; KCNA11; KV7.2 | potassium voltage-gated channel subfamily Q member 2 |
| TCMBANKGE011805 | KCNH1 | EAG; EAG1; Kv10.1; TMBTS; ZLS1; h-eag; hEAG; hEAG1 | potassium voltage-gated channel subfamily H member 1 |
| TCMBANKGE012006 | MED18 | SRB5; p28b | mediator complex subunit 18 |
| TCMBANKGE001201 | MAPK3 | ERK-1; ERK1; ERT2; HS44KDAP; HUMKER1A; P44ERK1; P44MAPK; PRKM3; p44-ERK1; p44-MAPK | mitogen-activated protein kinase 3 |
| TCMBANKGE011279 | NRXN1 | Hs.22998; PTHSL2; SCZD17 | neurexin 1 |
| TCMBANKGE000276 | NOS1 | IHPS1; N-NOS; NC-NOS; NOS; bNOS; nNOS | nitric oxide synthase 1 |
| TCMBANKGE011954 | TARDBP | ALS10; TDP-43 | TAR DNA binding protein |
| TCMBANKGE000186 | IGF2 | C11orf43; GRDF; IGF-II; PP9974 | insulin like growth factor 2 |
| TCMBANKGE008393 | GRN | CLN11; GEP; GP88; PCDGF; PEPI; PGRN | granulin precursor |
| TCMBANKGE012330 | LIMK1 | LIMK; LIMK-1 | LIM domain kinase 1 |
| TCMBANKGE001504 | TOP3B | TOP3B1 | DNA topoisomerase III beta |
| TCMBANKGE011160 | CLSTN1 | ALC-ALPHA; CDHR12; CST-1; CSTN1; PIK3CD; XB31alpha; alcalpha1; alcalpha2 | calsyntenin 1 |
| TCMBANKGE004957 | SHANK1 | SPANK-1; SSTRIP; synamon | SH3 and multiple ankyrin repeat domains 1 |
| TCMBANKGE005653 | GRIN2A | EPND; FESD; GluN2A; LKS; NMDAR2A; NR2A | glutamate ionotropic receptor NMDA type subunit 2A |
| TCMBANKGE006611 | ST8SIA4 | PST; PST1; SIAT8D; ST8SIA-IV | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
| TCMBANKGE010695 | ADARB1 | ADAR2; DRABA2; DRADA2; NEDHYMS; RED1 | adenosine deaminase RNA specific B1 |
| TCMBANKGE000725 | FOSL1 | FRA; FRA1; fra-1 | FOS like 1, AP-1 transcription factor subunit |
| TCMBANKGE003452 | UBE3A | ANCR; AS; E6-AP; EPVE6AP; HPVE6A | ubiquitin protein ligase E3A |
| TCMBANKGE006877 | MLH1 | COCA2; FCC2; HNPCC; HNPCC2; hMLH1 | mutL homolog 1 |
| TCMBANKGE003625 | SLC6A4 | 5-HTT; 5-HTTLPR; 5HTT; HTT; OCD1; SERT; SERT1; hSERT | solute carrier family 6 member 4 |
| TCMBANKGE006367 | SHC2 | SCK; SHCB; SLI | SHC adaptor protein 2 |
| TCMBANKGE000306 | PIK3CG | PI3CG; PI3K; PI3Kgamma; PIK3; p110gamma; p120-PI3K | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
| TCMBANKGE011776 | EIF4E | AUTS19; CBP; EIF4E1; EIF4EL1; EIF4F; eIF-4E | eukaryotic translation initiation factor 4E |
| TCMBANKGE000236 | BDNF | ANON2; BULN2 | brain derived neurotrophic factor |
| TCMBANKGE009666 | SLC36A1 | Dct1; LYAAT1; PAT1; TRAMD3 | solute carrier family 36 member 1 |
| TCMBANKGE000411 | IRF6 | LPS; OFC6; PIT; PPS; PPS1; VWS; VWS1 | interferon regulatory factor 6 |
| TCMBANKGE000783 | PCSK9 | FH3; FHCL3; HCHOLA3; LDLCQ1; NARC-1; NARC1; PC9 | proprotein convertase subtilisin/kexin type 9 |
| TCMBANKGE005857 | Pax3 | Pax-3; Sp; Splchl2; splotch | paired box 3 |
| TCMBANKGE000771 | TWIST1 | ACS3; BPES2; BPES3; CRS; CRS1; CSO; SCS; SWCOS; TWIST; bHLHa38 | twist family bHLH transcription factor 1 |
| TCMBANKGE003670 | ABCB6 | ABC; LAN; MTABC3; PRP; umat | ATP binding cassette subfamily B member 6 (Langereis blood group) |
| TCMBANKGE009702 | USF2 | FIP; bHLHb12 | upstream transcription factor 2, c-fos interacting |
| TCMBANKGE007674 | MAK16 | MAK16L; RBM13 | MAK16 homolog |
| TCMBANKGE010146 | PDLIM5 | ENH; ENH1; L9; LIM | PDZ and LIM domain 5 |
| TCMBANKGE003271 | RGS4 | RGP4; SCZD9 | regulator of G protein signaling 4 |
| TCMBANKGE006511 | PTBP1 | HNRNP-I; HNRNPI; HNRPI; PTB; PTB-1; PTB-T; PTB2; PTB3; PTB4; pPTB | polypyrimidine tract binding protein 1 |
滇IICP备16009434号-1 |
Dai SX Lab